Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
Titel:
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
Auteur:
Adams, S. Schmid, P. Rugo, H.S. Winer, E.P. Loirat, D. Awada, A. Cescon, D.W. Iwata, H. Campone, M. Nanda, R. Hui, R. Curigliano, G. Toppmeyer, D. O’Shaughnessy, J. Loi, S. Paluch-Shimon, S. Tan, A.R. Card, D. Zhao, J. Karantza, V. Cortés, J.